The MRC Centre for Transplantation at King's College London combines expertise in basic immunology and transplant biology with a large clinical transplantation programme at its partner NHS Trusts at Guy's and St Thomas' NHS Foundation Trust and King's College Hospital NHS Foundation Trust. It has as its central aim conducting high-quality basic scientific research and facilitating the clinical application of innovative biological technologies in order to improve the health of transplant recipients.
Ethical and legal inquiry and commentary on scientific and medical advances in transplantation, and indeed other areas of expertise, is an essential component of research translation. It should not be regarded simply as a means of providing a justification for scientific research, but rather as a way of examining and understanding its role in society and its impact on public health. In the context of organ transplantation it requires, among other things, a commitment to promoting dialogue with interdisciplinary colleagues and the public about ethical issues related to organ donation and transplantation, the role and responsibility of science and technology in transplantation and the impact that transplantation has on society as a whole.
Ethical issues in transplantation are highly complex. In the UK, as elsewhere, academic debate has long since evolved beyond models of deceased organ donation and ongoing campaigns for systems of 'opting-in' and 'optingout'. There is almost unanimous agreement on the societal benefits of increasing the number of donor organs, and a general acknowledgement of the good effects scientific research has played in the development and remarkable success of clinical transplantation. However, controversy remains about the status of body parts, and, in particular in the context of deceased donation, the legitimacy of research and preparatory measures to preserve organs with the objective of organ retrieval and transplantation. In the UK, these matters have recently come to the fore prompted by the considerable increase in the number of organs retrieved from donors following a diagnosis of circulatory/cardiac death (DCD).
In order to address these issues the MRC Centre for Transplantation hosted a Winter Ethics Symposium, 'The ethics of organ retrieval: goals, rights and responsibilities'. The symposium, held in December 2010 in collaboration with the British Transplantation Society Ethics Committee, was made possible by a grant from the Wellcome Trust. The meeting was attended by members of the Secretary of State's Organ Donation Taskforce (ODTF); members of the UK Donation Ethics Committee (UKDEC); representatives from the Department of Health, the Human Tissue Authority, NHS Blood and Transplant, the Nuffield Council on Bioethics, and the Wellcome Trust; academic lawyers, ethicists and social scientists; senior clinicians and researchers; students from these disciplines; and the general public. It provided a unique forum for a diverse set of professionals involved in organ donation and transplantation to come together to discuss ethical issues raised by organ retrieval and the impact that these continue to have on the delivery of clinical transplant services, transplant research and transplant outcome. It also provided an opportunity for senior clinicians and researchers involved in organ donation and transplantation to set out the clinical goals of organ donation and transplantation and to engage with academic lawyers, ethicists, policy makers and key stakeholders about the difficult challenges that current ethical, legal and regulatory policy frameworks present.
The key issues affecting deceased donor organ retrieval discussed at the symposium were (a) the impact on clinical transplant services of retrieving 'extended criteria' deceased donor organs; (b) the indications for referral for brainstem death testing and organ donation; (c) organ donation following diagnosis of cardiac death (DCD); (d) organ donation following diagnosis of brainstem death (DBD); (e) supporting organ donation through end-of-life care and the implications of this for DCD and DBD; (f ) optimizing deceased donor organ potential in the UK; and (g) conducting transplant research on the deceased and the effect of licensing requirements on this.
The papers in this special thematic issue of Clinical Ethics provide timely and incisive commentary on these key issues. They include a presentation of the empirical facts and issues confronted in everyday clinical practice; an examination of whether it is ethically permissible to manage the end-of-life care of a dying patient to maximize the chances of successful transplantation; an ethical and legal inquiry into supporting organ donation through end-of-life care and, in particular, the implications for donation after brainstem death (DBD); an overview of donor potential donor in the UK, and reflections on how donor potential can be optimized; an examination of the negative influence the Human Tissue Act (2004) and its licensing requirements has on transplantation research; and finally an exploration of the European Union Directive on Organ Donation and Transplantation, its development and its implications for organ donation and transplantation in the UK.
The first report of the ODTF Organs for Transplants, published in January 2008, recognized the importance of resolving ethical and legal controversies and providing clear guidance for practising clinicians involved in organ donation and the retrieval process. 1 In order for this ambitious task to be realized, it requires us to be responsive to the depth and complexity of the controversial issues involved. With the establishment of UKDEC, and its workstreams, the UK is well equipped to take these issues forward. But, as we hope that the proceedings from the MRC Centre for Transplantation Winter Ethics Symposium published in this special issue of Clinical Ethics highlight, we should not underestimate the important role that interdisciplinary dialogue and academic scholarship in medical ethics and law, and social science has to play in the translation of innovative transplant biology into everyday clinical practice, and the development of effective public policy in this domain.
